Ignite Creation Date:
2024-05-06 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04709510
Status:
COMPLETED
Last Update Posted:
2021-01-14
First Post:
2021-01-08
Brief Title:
Short-term Perioperative Thromboprophylaxis After Major Abdominal Surgery
Sponsor:
Istanbul Medeniyet University
Organization:
Istanbul Medeniyet University
Study Overview
Official Title:
Outcomes of Short-term Perioperative Thromboprophylaxis After Gastrointestinal Cancer Surgery
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Major abdominal surgery for cancer is major risk factor for thromboembolism Patients who undergo major abdominal surgery are prone to develop venous thromboembolism both in the early postoperative period and after hospital discharger There are strong recommendations in the international guidelines in favor to pharmacological thromboprophylaxis Thus there is no consensus dor the duration of the prophylaxis There are authors that suggest extended prophylaxis up to 4 week after surgery On the other hand there are prospective randomized trials that inpatient short-term up to 7-10 days prophylaxis is adequate
Detailed Description:
This is a retrospective cohort study with 89 patients who underwent major abdominal surgery for colorectal and gastric cancer All patients received short term prophylaxis during hospital stay only rather than extended prophylaxis 4 weeks All participants received duplex ultrasound in the study period for the diagnosis of deep vein thrombosis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None